• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

菲律宾 CORONA 研究:COVID-19 合并冠心病和心力衰竭患者的结局。

Outcomes of patients with COVID-19 and coronary artery disease and heart failure: findings from the Philippine CORONA study.

机构信息

Department of Neurosciences, College of Medicine and Philippine General Hospital, University of the Philippines Manila, Manila, Philippines.

Department of Clinical Epidemiology, College of Medicine, University of the Philippines Manila, Manila, Philippines.

出版信息

BMC Res Notes. 2024 Jan 4;17(1):14. doi: 10.1186/s13104-023-06677-5.

DOI:10.1186/s13104-023-06677-5
PMID:38178236
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10768280/
Abstract

BACKGROUND

Patients with coronavirus disease 2019 (COVID-19) and coronary artery disease (CAD) or heart failure (HF) are more likely to have poor outcomes. This study aimed to determine the characteristics and outcomes of COVID-19 patients with CAD/HF across various institutions in the Philippines.

METHODS

We utilized the data from the Philippine CORONA Study and compared the outcomes of admitted COVID-19 patients with CAD/HF versus those without. The Student's t test, Mann-Whitney U test, binary logistic regression and multivariate regression analysis were utilized. Odds ratios (OR) and Kaplan-Meier curves were generated.

RESULTS

We included a total of 512 patients with COVID-19 had CAD/HF and 10,369 were without. CAD/HF was significantly associated with COVID severity, all-cause mortality, death from cardiac causes, respiratory failure, and prolonged hospitalization. After adjusting for confounders, the presence of CAD/HF was still associated with death from a cardiac cause (OR 2.22, 95% CI 1.49-3.3, p < 0.01).

CONCLUSIONS

The presence of CAD or HF was significantly associated with severity of COVID disease, all-cause mortality, death from cardiac causes, respiratory failure, and prolonged hospitalization.

摘要

背景

患有 2019 年冠状病毒病(COVID-19)和冠心病(CAD)或心力衰竭(HF)的患者更有可能出现不良结局。本研究旨在确定菲律宾各医疗机构 COVID-19 合并 CAD/HF 患者的特征和结局。

方法

我们利用菲律宾 CORONA 研究的数据,比较了住院 COVID-19 患者合并 CAD/HF 与不合并 CAD/HF 的结局。采用 Student's t 检验、Mann-Whitney U 检验、二项逻辑回归和多变量回归分析。生成比值比(OR)和 Kaplan-Meier 曲线。

结果

我们共纳入 512 例 COVID-19 合并 CAD/HF 患者和 10369 例不合并 CAD/HF 患者。CAD/HF 与 COVID-19 严重程度、全因死亡率、心源性死亡、呼吸衰竭和住院时间延长显著相关。调整混杂因素后,CAD/HF 的存在仍与心源性死亡相关(OR 2.22,95%CI 1.49-3.3,p<0.01)。

结论

CAD 或 HF 的存在与 COVID-19 疾病的严重程度、全因死亡率、心源性死亡、呼吸衰竭和住院时间延长显著相关。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d16a/10768280/5ab7a542d5af/13104_2023_6677_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d16a/10768280/5ab7a542d5af/13104_2023_6677_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d16a/10768280/5ab7a542d5af/13104_2023_6677_Fig1_HTML.jpg

相似文献

1
Outcomes of patients with COVID-19 and coronary artery disease and heart failure: findings from the Philippine CORONA study.菲律宾 CORONA 研究:COVID-19 合并冠心病和心力衰竭患者的结局。
BMC Res Notes. 2024 Jan 4;17(1):14. doi: 10.1186/s13104-023-06677-5.
2
The outcomes of patients with diabetes mellitus in The Philippine CORONA Study.菲律宾 CORONA 研究中糖尿病患者的结局。
Sci Rep. 2021 Dec 24;11(1):24436. doi: 10.1038/s41598-021-03898-1.
3
The Philippine OVID-19 utcomes: a etrospective study f eurological manifestations and ssociated symptoms (The Philippine study): a protocol study.菲律宾新冠疫情结果:一项关于神经学表现及相关症状的回顾性研究(菲律宾研究):一项方案研究。
BMJ Open. 2020 Nov 30;10(11):e040944. doi: 10.1136/bmjopen-2020-040944.
4
Importance of Nonobstructive Coronary Artery Disease in the Prognosis of Patients With Heart Failure.非阻塞性冠状动脉疾病对心力衰竭患者预后的重要性。
JACC Heart Fail. 2019 Jun;7(6):493-501. doi: 10.1016/j.jchf.2019.02.014. Epub 2019 May 8.
5
Joint effect of heart failure and coronary artery disease on the risk of death during hospitalization for COVID-19.心力衰竭和冠心病对 COVID-19 住院期间死亡风险的联合影响。
Eur J Intern Med. 2021 Jul;89:81-86. doi: 10.1016/j.ejim.2021.04.007. Epub 2021 Apr 19.
6
Temporal trends in characteristics and outcome of heart failure patients with and without significant coronary artery disease.有和无显著冠状动脉疾病的心力衰竭患者特征和结局的时间趋势。
ESC Heart Fail. 2022 Jun;9(3):1812-1822. doi: 10.1002/ehf2.13875. Epub 2022 Mar 8.
7
WBC count predicts heart failure in diabetes and coronary artery disease patients: a retrospective cohort study.白细胞计数可预测糖尿病合并冠心病患者的心力衰竭:一项回顾性队列研究。
ESC Heart Fail. 2021 Oct;8(5):3748-3759. doi: 10.1002/ehf2.13513. Epub 2021 Jul 15.
8
Clinical outcomes in COVID-19 among patients with hypertension in the Philippine CORONA Study.菲律宾 CORONA 研究中高血压患者 COVID-19 的临床结局。
Eur J Med Res. 2023 Feb 3;28(1):62. doi: 10.1186/s40001-022-00969-5.
9
Influence of documented history of coronary artery disease on outcomes in patients admitted for worsening heart failure with reduced ejection fraction in the EVEREST trial.在 EVEREST 试验中,记录的冠心病病史对射血分数降低的心力衰竭恶化患者的结局的影响。
Eur J Heart Fail. 2013 Jan;15(1):61-8. doi: 10.1093/eurjhf/hfs139. Epub 2012 Sep 11.
10
An increase in the coronary calcification score is associated with an increased risk of heart failure in patients without a history of coronary artery disease.在没有冠状动脉疾病病史的患者中,冠状动脉钙化评分的增加与心力衰竭风险的增加相关。
J Cardiol. 2016 Apr;67(4):358-64. doi: 10.1016/j.jjcc.2015.06.014. Epub 2015 Aug 5.

引用本文的文献

1
Exploring genetic loci linked to COVID-19 severity and immune response through multi-trait GWAS analyses.通过多性状全基因组关联研究分析探索与新冠病毒疾病严重程度和免疫反应相关的基因位点。
Front Genet. 2025 Feb 17;16:1502839. doi: 10.3389/fgene.2025.1502839. eCollection 2025.

本文引用的文献

1
Clinical Outcomes of COVID-19 Infection among Patients with Chronic Obstructive Pulmonary Disease: Findings from the Philippine CORONA Study.慢性阻塞性肺疾病患者感染新型冠状病毒肺炎的临床结局:菲律宾CORONA研究结果
Clin Pract. 2023 Nov 10;13(6):1383-1392. doi: 10.3390/clinpract13060124.
2
Clinical outcomes in COVID-19 among patients with hypertension in the Philippine CORONA Study.菲律宾 CORONA 研究中高血压患者 COVID-19 的临床结局。
Eur J Med Res. 2023 Feb 3;28(1):62. doi: 10.1186/s40001-022-00969-5.
3
Incidence and risk factors for stroke in patients with COVID-19 in the Philippines: An analysis of 10,881 cases.
菲律宾 COVID-19 患者卒中的发生率和危险因素:对 10881 例病例的分析。
J Stroke Cerebrovasc Dis. 2022 Nov;31(11):106776. doi: 10.1016/j.jstrokecerebrovasdis.2022.106776. Epub 2022 Sep 8.
4
Body mass index and its association with COVID-19 clinical outcomes: Findings from the Philippine CORONA study.体重指数及其与 COVID-19 临床结局的关联:菲律宾 CORONA 研究的结果。
Clin Nutr ESPEN. 2022 Jun;49:402-410. doi: 10.1016/j.clnesp.2022.03.013. Epub 2022 Mar 31.
5
Outcomes and Risk Factors of Patients With COVID-19 and Cancer (ONCORONA): Findings from The Philippine CORONA Study.新冠病毒肺炎合并癌症患者的结局与风险因素(ONCORONA):菲律宾CORONA研究结果
Front Oncol. 2022 Apr 13;12:857076. doi: 10.3389/fonc.2022.857076. eCollection 2022.
6
Effect of Coronary Artery Disease on COVID-19-Prognosis and Risk Assessment: A Systematic Review and Meta-Analysis.冠状动脉疾病对COVID-19预后及风险评估的影响:一项系统评价与荟萃分析
Biology (Basel). 2022 Jan 29;11(2):221. doi: 10.3390/biology11020221.
7
COVID-19 and chronic kidney disease: an updated overview of reviews.COVID-19 与慢性肾脏病:系统评价的更新概述。
J Nephrol. 2022 Jan;35(1):69-85. doi: 10.1007/s40620-021-01206-8. Epub 2022 Jan 11.
8
The outcomes of patients with diabetes mellitus in The Philippine CORONA Study.菲律宾 CORONA 研究中糖尿病患者的结局。
Sci Rep. 2021 Dec 24;11(1):24436. doi: 10.1038/s41598-021-03898-1.
9
The isolated effect of age on the risk of COVID-19 severe outcomes: a systematic review with meta-analysis.年龄对 COVID-19 严重结局风险的孤立影响:系统评价与荟萃分析。
BMJ Glob Health. 2021 Dec;6(12). doi: 10.1136/bmjgh-2021-006434.
10
Smoking and COVID-19 outcomes: an observational and Mendelian randomisation study using the UK Biobank cohort.吸烟与 COVID-19 结局:一项使用英国生物库队列的观察性和孟德尔随机化研究。
Thorax. 2022 Jan;77(1):65-73. doi: 10.1136/thoraxjnl-2021-217080. Epub 2021 Sep 27.